[1] Rosebush MS，Rao SK，Samant S，et al.Oral cancer:enduring characteristics and emerging trends[J].J Mich Dent Assoc，2012，94(2):64-68.
[2] Dissanayaka WL，Pitiyage G，Kumarasiri PV，et al.Clinical and histopathologic parameters in survival of oral squamous cell carcinoma[J].Oral Surg Oral Med Oral Pathol Oral Radiol，2012，113(4):518-525.
[3] Mrgritescu C，Pirici D，Simionescu C，et al.VEGF and VEGFRs expression in oral squamous cell carcinoma[J].Rom J Morphol Embryol，2009，50(4):527-548.
[4] Campo-Trapero J，Cano-Snchez J，Palacios-Snchez B，et al.Update on molecular pathology in oral cancer and precancer[J].Anticancer Res，2008，28(2B):1197-1205.
[5] Sanderson RD，Iozzo RV.Targeting heparanase for cancer therapy at the tumor-matrix interface[J].Matrix Biol，2012，31(5):283-284.
[6] Doweck I，Kaplan-Cohen V，Naroditsky I，et al.Heparanase localization and expression by head and neck cancer:correlation with tumor progression and patient survival[J].Neoplasia，2006，8(12):1055-1061.
[7] Li JP.Heparin，heparan sulfate and heparanase in cancer:remedy for metastasis[J].Anticancer Agents Med Chem，2008，8(1):64-76.
[8] Li JP，Spillmann D.Heparan sulfate proteoglycans as multifunctional cell regulators:cell surface receptors[J].Methods Mol Biol，2012，836:239-255.
[9] Nadir Y，Vlodavsky I，Brenner B.Heparanase，tissue factor，and cancer[J].Semin Thromb Hemost，2008，34(2):187-194.
[10] Teng YH，Aquino RS，Park PW.Molecular functions of syndecan-1 in disease[J].Matrix Biol，2012，31(1):3-16.
[11] Arvatz G，Shafat I，Levy-Adam F，et al.The heparanase system and tumor metastasis:is heparanase the seed and soil?[J].Cancer Metastasis Rev，2011，30(2):253-268.
[12] Leiser Y，Abu-El-Naaj I，Sabo E，et al.Prognostic value of heparanase expression and cellular localization in oral cancer[J].Head Neck，2011，33(6):871-877.
[13] Vlodavsky I，Elkin M，Abboud-Jarrous G，et al.Heparanase:one molecule with multiple functions in cancer progression[J].Connect Tissue Res，2008，49(3):207-210.
[14] Nagler R，Ben-Izhak O，Cohen-Kaplan V，et al.Heparanase up-regulation in tongue cancer:tissue and saliva analysis[J].Cancer，2007，110(12):2732-2739.
[15] Wang F，Kim MS，Puthanveetil P，et al.Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid[J].Am J Physiol Heart Circ Physiol，2009，296(4):H1108-H1116.
[16] Kurokawa H，Zhang M，Matsumoto S，et al.Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma[J].J Oral Pathol Med，2006，35(5):301-306.
[17] Jackson LL，Wade Z，Hessler RB，et al.Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity[J].Laryngoscope，2007，117(5):868-871.
[18] Yoshikawa K，Hamada J，Tada M，et al.Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells[J].Biomed Res，2010，31(6):401-411.
[19] Nmeth Z，Szigeti K，Mth M，et al.Effect of induction chemotherapy on changes of laminin and syndecan expression in oral squamous cell carcinomas:a prospective，randomized，clinicopathologic and immunohistochemical study[J].J Craniofac Surg，2005，16(2):205-212.
[20] Ben-Izhak O，Akrish S，Nagler RM.Ki67 and salivary cancer[J].Cancer Invest，2008，26(10):1015-1023.
[21] Cripps C，Winquist E，Devries MC，et al.Epidermal growth factor receptor targeted therapy in stages Ⅲ and Ⅳ head and neck cancer[J].Curr Oncol，2010，17(3):37-48.
[22] Harandi A，Zaidi AS，Stocker AM，et al.Clinical efficacy and toxicity of anti-EGFR therapy in common cancers[J].J Oncol，2009，2009：567486.
[23] Hamakawa H，Nakashiro K，Sumida T，et al.Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer[J].Head Neck，2008，30(6):800-809.
[24] Zhang L，Sullivan P，Suyama J，et al.Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase Ⅰ activity in brain metastatic breast cancer[J].Mol Cancer Res，2010，8(2):278-290.
[25] Kaur Saini M，Kaur J，Sharma P，et al.Chemopreventive response of diclofenac，a on-steroidal anti-inflammatory drug in experimental carcinogenesis[J].Nutr Hosp，2009，24(6):717-723.
[26] Rivera RS，Nagatsuka H，Siar CH，et al.Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma[J].Oncol Rep，2008，19(3):657-661.